This review article discusses the controversies on the roles of DAGs in insulin resistance
What They Are and Whats Actually Being Sold Marketing claims often suggest these patches can help curb appetite, reduce cravings, or support GLP-1 activity. However, theres no strong clinical evidence showing that these patches produce GLP-1like weight loss results, especially when compared with prescription medications that have been rigorously studied in humans
Not because of injection frequency (both used therapeutic doses) but because of adherence verification, resistance training progression, and adequate protein intake to preserve lean mass during the deficit
In its SURMOUNT-1 trial at the 15 mg dose, tirzepatide produced an average weight loss of about 20% of total body weight over the study period
Its role in fatty-acid oxidation is well established in basic science, and its been used clinically for decades in settings where mitochondrial function needs explicit support
Appetite stimulation is minimal or absent in most users
